Ensefalit: Tanı ve Tedavi

Yazarlar

Özet

Ensefalit, beyin dokusunun inflamasyonu ile karakterize ciddi bir nörolojik acil durumdur. Viral, bakteriyel, otoimmün ve özellikle immünsuprese kişilerde fungal hatta parazitik nedenlere bağlı gelişebilir. Klinik belirtiler; baş ağrısı, ateş, bilinç bulanıklığı, nöbetler ve fokal nörolojik defisitlerdir. Tanıda anamnez, nörolojik muayene, beyin omurilik sıvısı (BOS) analizi, Beyin görüntüleme ve Polimeraz Zincir Reaksiyonu (PCR) testi önemlidir. Herpes Simpleks Virüs (HSV) PCR testi duyarlılık ve özgüllük oranları %95'in üzerinde bildirilmiştir. Özellikle Amerika Bulaşıcı Hastalıklar Derneği kılavuzlarına göre, PCR testi yapılmadan HSV ensefalitinin dışlanmaması gerektiği belirtilir. Tedavi etiyolojiye göre değişir; HSV ensefalitinde acil olarak intravenöz asiklovir başlanmalıdır. HSV ensefaliti dışındaki ensefalitlerde tedavi, etiyolojiye göre değişkenlik gösterir. Otoimmün ensefalitte immünsupresif tedavi (kortikosteroidler, intravenöz İmmünoglobulin veya plazmaferez) tercih edilirken, bakteriyel ensefalitte geniş spektrumlu antibiyotikler hızlıca başlanmalıdır. Her vakada tedavi, altta yatan nedene göre değişmektedir. Komplikasyonların yönetimi, yoğun bakım desteği ve uzun süreli nörolojik takip gerektirir. Erken tanı ve tedavi prognoz belirleyicidir.

Referanslar

Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327.

Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults–Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64(4):347-373.

Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835-844.

Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74.

Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol. 2014;27(3):361-368.

Whitley RJ, Cobbs CG, Alford CA Jr, et al. Diseases that mimic herpes simplex encephalitis. Clin Infect Dis. 1987;9(1):147-165.

Gilden DH, Cohrs RJ, Mahalingam R. Varicella-zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731-740.

Tyler KL. Emerging viral infections of the central nervous system: part 1. Arch Neurol. 2009;66(8):939-948.

Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(10):766-774.

Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4(12):725-738.

Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481-492.

Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27(1):86-92.

Schlech WF 3rd, Lavigne PM, Bortolussi RA, et al. Epidemic listeriosis--evidence for transmission by food. N Engl J Med. 1983;308(4):203-206.

Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol. 2013;12(10):999-1010.

Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 1998;339(4):209-215.

Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135(Pt 5):1622-1638.

Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-1976.

Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291-322.

Pappas, P. G., Kauffman, C. A., Andes, D., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., ... & Sobel, J. D. (2016). Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 62(4), e1-e50.

Tang Y, Durand ML, Durrani K. Viral Encephalitis: A Review of Diagnostic Methods and Guidelines for Management. Brain Sci. 2018;8(10):177.

Hart J Jr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14:248.

Hacohen Y, Absoud M, Deiva K, et al. NMDA receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Neurology. 2014;83(5):467-473.

Venkatesan A. Epidemiology and outcomes of acute encephalitis. Curr Opin Neurol. 2015;28(3):277-282.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20.

Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290(4):511-515.

Wang S, Li W, Kang J, et al. Psychotic symptoms as initial manifestation in Chinese children with anti-NMDAR encephalitis. Brain Dev. 2014;36(4):293-300.

Dalmau J, Armangue T, Planaguma J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045-1057.

Granerod J, Davies NW, Mukonoweshuro W, et al. Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement. Clin Radiol. 2016;71(10):1050-1058.

Venkatesan A, Tunkel AR, Bloch KC, et al. Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium. Clin Infect Dis. 2013;57(8):1114-1128.

Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022. s1094-1100.

Pritchard AJ, Mukonoweshuro W, Davies NWS, et al. MR imaging findings in viral encephalitis: A systematic review of the literature. J Clin Neurosci. 2020;72:39-45.

Husain, A. M. (2006). "Electroencephalographic assessment of encephalitis." Journal of Clinical Neurophysiology, 23(5), 383-389.

Tyler, K. L. (2018). "Acute viral encephalitis." New England Journal of Medicine, 379(6), 558-566.

Dalmau, J., & Graus, F. (2018). "Antibody-mediated encephalitis." New England Journal of Medicine, 378(9), 840-851.

Anne Bertrand, Delphine Leclercq, Laurent Martinez-Almoyna, Nadine Girard, Jean Paul Stahl, et al.. MR imaging of adult acute infectious encephalitis. Médecine et Maladies Infectieuses, 2017, ff10.1016/j.medmal.2017.01.002ff. ffhal-01490868

Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J. 2003;79(927):11–7.

Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 2007;68(16 Suppl 2)

Auger C, Rovira À. Acute Disseminated Encephalomyelitis and Other Acute Parainfectious Syndromes. In: Barkhof F, Jäger H, Thurnher M, Rovira À, editors. Clinical Neuroradiology. Cham: Springer; 2019:789–91. https://doi.org/10.1007/978-3-319-68536-6_53

Tenembaum S., Chitnis T., Ness J., & Hahn J. S. (2007). Acute disseminated encephalomyelitis. Neurology, 68(16 suppl 2), 23-S36.

Dalmau J., Tüzün E., Wu H. Y., Masjuan J., Rossi J. E. et al. (2008). Paraneoplastic anti–NMDA receptor encephalitis associated with ovarian teratoma. Annals of Neurology, 61(1), 25-36

Sutter R., Kaplan P. W., & Rüegg S. (2016). Outcome predictors for status epilepticus–what really counts. Nature Reviews Neurology, 12(8), 548-632.

Ellul M., & Solomon T. (2018). Acute encephalitis – diagnosis and management. Clinical Medicine, 18(2), 155-159.Mar S, Lenka D, Zou H. Management of autoimmune encephalitis: an update. Curr Treat Options Neurol. 2020;22(1):2-12.

Wilson M. R., Sample H. A., Zorn K. C., Arevalo S., et al. (2019). Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. New England Journal of Medicine, 380(24), 2327-2340.

Gelecek

28 Şubat 2025

Lisans

Lisans